glp 1 and glp 2 drugs GLP-1 are all approved for glucose control in type diabetes (T2D). Some of them also have additional indications reflecting their demonstrated benefits for cardiovascular disease, kidney health, obesity. None GLP-1 and Inflammation: How These

If you are struggling with dietary compliance, say so

Tirzepatide users were less likely to experience any major cardiovascular problems following surgery than people not on the drug (roughly 30% lower risk), though the rate of some problems like heart attacks remained roughly the same between the two groups

doi: 10.1111/DOM.14055 15 GiorginoFVoraJFeniciPSoliniA

Acknowledgements This work was supported by the National Institute for Health and Care Research (NIHR) Leicester Biomedical Research Centre

Wegovy is approved for obesity at doses up to 2.4 mg weekly

Psoriatic Arthritis & Psoriasis Obesity worsens both skin and joint disease